The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,516.00
Bid: 12,554.00
Ask: 12,556.00
Change: 112.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,500.00
High: 12,586.00
Low: 12,444.00
Prev. Close: 12,404.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ireland Eyes Vaccines For All Adults By September Despite Supply Fears

Tue, 26th Jan 2021 16:10

(Alliance News) - Ireland's target remains to vaccinate every adult in the country by September, despite disruptions to the supply chain, the upper house of the country's legislature, has heard.

Junior Minister Anne Rabbitte, speaking on behalf of the Health Minister, said the Irish government has "significant concerns" that one vaccine producer, AstraZeneca PLC, will be unable to meet its initial delivery commitments.

This has led to some "adjustments" to the government's target of vaccinating 700,000 people by the end of March, Rabbitte said.

The goal of vaccinating all adults by September remains the target, but it is contingent on steady flow of vaccines.

Rabbitte said: "The minister for health previously stated that he expected all adult residents to be vaccinated by September.

"That remains our target.

"However, as Minister Donnelly stressed, it is contingent on existing commitments on the approval, supply and delivery of vaccines."

The AstraZeneca vaccine is crucial to the government's planned vaccine delivery schedule.

It is scheduled for approval by the European Medicines Agency on Friday, but the company recently announced it will initially supply considerably fewer doses than agreed with the EU.

The announcement has caused outrage in the EU, which pre-financed the production and delivery of the vaccine.

The new delivery schedule is "not acceptable", European Health Commissioner Stella Kyriakides has warned the company.

On Tuesday, Rabbitte also criticised the company over the delays.

She said: "Of significant concern is the recent indication that AstraZeneca will not be available to meet its initial delivery commitments.

"It is estimated that deliveries in February will be at the low range of what was anticipated, and there will be further significant impact in March.

"The Department of Health is monitoring this change of situation, and is continually engaging with the commission and the company.

"The minister is very concerned that this supply issue was only communicated to the member states just a week before the scheduled authorisation was to be given for the vaccine."

Rabbitte also warned that the arrival of the vaccines and the prospect of a return to normality "gives rise to public expectation that cannot be met in the short term".

The EU had expected to receive 100 million doses of the AstraZeneca vaccine in the first quarter of the year.

It is now feared it will receive only half that amount.

Brussels has threatened to block exports of Covid-19 vaccines outside of the bloc as a result of the ongoing row.

As of Sunday, the HSE has administered 143,000 vaccine doses in Ireland.

Two doses delivered three or four weeks apart are required for the vaccines currently in use in Ireland, Pfizer Inc/BioNTech SE and Moderna Inc.

The HSE began administration of the second doses of the vaccine last week.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
1 Dec 2023 08:52

LONDON MARKET OPEN: Miners give FTSE 100 boost thanks to China PMI

(Alliance News) - Stock prices in London opened higher on Friday, with the FTSE 100 boosted by mining stocks.

Read more
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.